Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful treatment with high-dose intravenous immunoglobulin in a patient with spontaneous inhibitor to factor VIII.

Literature DB >> 3081068

Successful treatment with high-dose intravenous immunoglobulin in a patient with spontaneous inhibitor to factor VIII.

E Hiller, E Holler, R G Geursen, H Riess.

Abstract

Entities: Species

Mesh：

Substances：
Factor VIII

Year: 1986 PMID： 3081068 DOI： 10.1007/bf00321075

Source DB: PubMed Journal: Blut ISSN： 0006-5242

× No keyword cloud information.

11 in total

1. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.

Authors: Y Sultan; M D Kazatchkine; P Maisonneuve; U E Nydegger
Journal: Lancet Date: 1984-10-06 Impact factor: 79.321

2. Intravenous IgG for patients with spontaneous inhibitor to Factor VIII.

Authors: R Zimmermann; B Kommerell; J Harenberg; W Eich; K Rother; K Schimpf
Journal: Lancet Date: 1985-02-02 Impact factor: 79.321

3. Intravenous immunoglobulin therapy: new aspects and outlook.

Authors: P Imbach; S Barandun; C Baumgartner; G Gaedicke; A Hirt; H P Wagner
Journal: Blut Date: 1984-06

4. Specific and nonspecific mechanisms of action of immunoglobulin G in therapy of idiopathic thrombocytopenic purpura (ITP).

Authors: T W Jungi; P Imbach; S Barandun
Journal: Blut Date: 1984-06

5. Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone.

Authors: K D Herbst; S I Rapaport; D G Kenoyer; W Stanton; D I Feinstein
Journal: Ann Intern Med Date: 1981-11 Impact factor: 25.391

6. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

Authors: P Imbach; S Barandun; V d'Apuzzo; C Baumgartner; A Hirt; A Morell; E Rossi; M Schöni; M Vest; H P Wagner
Journal: Lancet Date: 1981-06-06 Impact factor: 79.321

7. Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: treatment with intravenous immunoglobulin. A case report.

Authors: A Gianella-Borradori; A Hirt; A Lüthy; H P Wagner; P Imbach
Journal: Blut Date: 1984-06

Successful treatment with high-dose intravenous immunoglobulin in a patient with spontaneous inhibitor to factor VIII.

1. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.

2. Intravenous IgG for patients with spontaneous inhibitor to Factor VIII.

3. Intravenous immunoglobulin therapy: new aspects and outlook.

4. Specific and nonspecific mechanisms of action of immunoglobulin G in therapy of idiopathic thrombocytopenic purpura (ITP).

5. Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone.

6. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

7. Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: treatment with intravenous immunoglobulin. A case report.

8. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.

9. Factor VIII antibodies in rheumatoid arthritis. Effect of cyclophosphamide.

10. Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors.

Review 1. Intravenous immunoglobulin therapy for acquired coagulation inhibitors: a critical review.

2. Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulin.